LATEST UPDATES, NATIONAL MILESTONES & MEDIA COVERAGE
Newsroom
Follow major announcements, national milestones, and media coverage of GenTraceDx, a precision oncology platform being introduced through a national clinical pilot across Canada, supported by Genome Canada and Genome British Columbia.
Latest Announcements & Milestones
Key announcements, national partnerships, and major milestones from GenTraceDx.
Genetrack Biolabs, working in partnership with Canada’s Michael Smith Genome Sciences Centre as part of a landmark research–industry collaboration, has […]
Federal funding supports genomic innovation projects in British Columbia, including initiatives advancing cancer diagnostics and clinical genomics. Read Article
Federal funding supports UBC-led genomics initiatives, including development of the GenTraceDx platform for clinical deployment and real-world cancer care. Read […]
Canadian Team Advances “Living” Cancer Diagnostic Platform Following National GAPP Funding
Genetrack Biolabs, working in partnership with Canada’s Michael Smith Genome Sciences Centre as part of a landmark research–industry collaboration, has announced the development of a ...
Read More →
Genome BC Announces Federal Funding to Advance Genomic Innovation
Federal funding supports genomic innovation projects in British Columbia, including initiatives advancing cancer diagnostics and clinical genomics. Read Article
Read More →
UBC Medicine Researchers Receive Federal Funding Supporting GenTraceDx Platform
Federal funding supports UBC-led genomics initiatives, including development of the GenTraceDx platform for clinical deployment and real-world cancer care. Read Article
Read More →
Canadian Team Advances “Living” Cancer Diagnostic Platform Following National GAPP Funding
GenTraceDx | March 2026
GenTraceDx introduces a continuously updating precision oncology platform, developed by Genetrack Biolabs and the Michael Smith Genome Sciences Centre and supported by national GAPP funding.
UBC Medicine Researchers Receive Federal Funding Supporting GenTraceDx Platform
University of British Columbia • March 2026
Federal funding supports UBC-led genomics initiatives, including development of the GenTraceDx platform for clinical deployment and real-world cancer care.
Genome BC Announces Federal Funding to Advance Genomic Innovation
Genome BC | March 2026
Federal funding supports genomic innovation projects in British Columbia, including initiatives advancing cancer diagnostics and clinical genomics.
Media Coverage
CBC News (Feature)
April 2025
Canadian team launches world’s first living cancer diagnostic powered by AI and multiomics.
Globe and Mail — Report on Business
April 2025
Genetrack Biolabs and GSC lead next generation of precision oncology.
GenomeWeb
March 2025
GenTraceDx introduces national multiomic cancer platform with continuous reanalysis capabilities.
Fierce Biotech
March 2025
Canadian innovation challenges static genomic testing with dynamic AI-enabled platform.”
Pilot Updates
Pilot Enrollment Opens Across All Provinces
Clinical partners in BC, Alberta, Ontario, and Quebec begin enrolling patients.
First RNA-Driven Therapy Opportunity Identified
Early pilot insight reveals a treatment option missed by panel sequencing.
Clinician Portal v1.2 Released
Improvements added for biomarker visualization and trial-matching precision.
Scientific & Technical Updates
New RNA Fusion Detection Pipeline Deployed
Expanded fusion detection for FGFR, NTRK, ALK, ROS1, RET, and rare translocations.
Pathway Activation Models Updated
Enhanced expression-based signaling for PI3K, MAPK, WNT, and Notch pathways.
Neoantigen Discovery Module Expanded
Improved MHC-binding prediction accuracy for personalized vaccine insights.
Longitudinal AI Engine v2.0
Adds real-time ingestion of biomarker papers and clinical cohort studies.
Media Resources
Official materials for media, partners, and institutional stakeholders.
Access the full library of press materials, including fact sheets, leadership profiles, and brand assets.
Access the full library of press materials, including fact sheets, leadership profiles, and brand assets.
Media Assets
Media Kit & Resources
Download official logos, images, and press materials.
Logos
GentraceDx Logo Dark (PNG)
GentraceDx Logo Light (PNG)
GentraceDx Logo Dark (SVG)
GentraceDx Logo Light (SVG)
Genetrack Logo
Michael Smith Genome Sciences Centre Logo (with permission)
Documents
Company Overview (PDF)
Overview of GenTraceDx, including platform design, clinical approach, and national pilot program.
Fact Sheet (PDF)
Key facts, program highlights, and summary of the GenTraceDx platform.
Quote Sheet (PDF)
Approved quotes from GenTraceDx leadership and scientific collaborators.
Platform Images
Gentrace Kit
Regulatory & Commercial Milestones
CLIA/CAP U.S. Lab Development Underway (2026)
GenTraceDx prepares for U.S. Medicare MolDX submission.
Canadian Compliance Milestone Achieved
Collection kits validated under ISO 13485 and Health Canada MDEL requirements.
PMA/CDx Program Planning Initiated
Selective biomarkers identified for future FDA PMA submissions.
Conferences & Presentations
ASCO 2026 (Chicago)
Presentation of early pilot data demonstrating multiomic detection and reanalysis impacts.
AACR 2026
Poster on AI-driven longitudinal evidence scanning for oncology.
ESMO 2026
Research presentation on multiomic clinical impact in real-world Canadian cohorts.
Genome Canada Innovation Forum
Keynote by Dr. June Wong on national genomics infrastructure and AI in oncology.
Awards & Recognition
2025
Genome Canada GAPP Award
National funding for GenTraceDx platform development and pilot deployment.
2026
Innovation in AI & Cancer Care
Recognized for pioneering the first living, continuously updating cancer diagnostic.
Canadian Precision Medicine Leadership Recognition
Awarded for building a pan-Canadian multiomic oncology infrastructure.
Press Kit & Media Requests
Media Contact
For interviews, statements, or access to spokespeople:
press@gentrace.com
XXX-XXX-XXXX
Investor Contact
For Series A inquiries and data room access:
investors@gentrace.com
Media Contact
For media inquiries and interview requests.
We welcome media coverage and collaboration to raise awareness of precision oncology and the GenTraceDx national pilot.
We welcome media coverage and collaboration to raise awareness of precision oncology and the GenTraceDx national pilot.
- Email: press@gentrace.com
- Website: www.gentrace.com